Quest Diagnostics announced the company’s board of directors has authorized a 7.6% increase in its quarterly dividend from 66c to 71c per share. The increase is effective with the dividend payable on April 24 to shareholders of record of Quest Diagnostics common stock on April 10. With the increase, the annual dividend will be $2.84 per share. The company has raised its dividend annually since 2011. Additionally, the board of directors has increased the company’s share repurchase authorization by $1B. The increased authority is in addition to the $311M that was available as of December 31, 2022 under the company’s share repurchase program.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on DGX:
- Quest Diagnostics sees FY23 adjusted EPS $8.40-$9.00, consensus $8.69
- Quest Diagnostics reports Q4 adjusted EPS $1.98, consensus $1.91
- QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2023
- Agilent, Quest team to extend access to Resolution ctDx FIRST NGS test
- Quest Diagnostics initiated with an In Line at Evercore ISI